We use analytics to improve your experience. Cookie policy
NYSE · Healthcare · Forecast
Wall Street targets, TECHi-approved analyst sentiment, and bull / base / bear scenarios on LLY.
Wall Street · Analyst views
Ratings, price targets, and the recommendation mix for the next 12 months.
Analysts tracked
39
Rating score
4.03
Median target
Not available
Consensus target
—
Median target
—
High target
—
Low target
—
Recommendation mix
Strong Buy
11
28% of 39
Buy
19
49% of 39
Hold
8
21% of 39
Sell
1
3% of 39
Strong Sell
0
0% of 39
Frequently asked
Wall Street analyst targets and the TECHi analyst consensus for Eli Lilly and Company are tracked on the TECHi LLY forecast page, with separate bull / base / bear scenarios.
Eli Lilly and Company ratings are tracked across TECHi-approved analysts and the broader Street. The forecast page shows the % bullish / hold / bearish split and links to the underlying analysis.
Twelve-month price targets — the median Wall Street target and the TECHi desk's bull / base / bear scenarios — are published on the TECHi LLY forecast page.
TECHi tracks every public price target it issues and grades them at 30, 90, and 180 days. Per-author accuracy is published on each analyst's profile.
